IN2013MU02286A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02286A
IN2013MU02286A IN2286MU2013A IN2013MU02286A IN 2013MU02286 A IN2013MU02286 A IN 2013MU02286A IN 2286MU2013 A IN2286MU2013 A IN 2286MU2013A IN 2013MU02286 A IN2013MU02286 A IN 2013MU02286A
Authority
IN
India
Prior art keywords
pharmaceutical
release
memantine
effective amount
time period
Prior art date
Application number
Other languages
English (en)
Inventor
Dutta Subhadeep
Kansagra Piyush
Singh Balvir
Sehgal Ashish
Original Assignee
Astron Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astron Res Ltd filed Critical Astron Res Ltd
Priority to IN2286MU2013 priority Critical patent/IN2013MU02286A/en
Publication of IN2013MU02286A publication Critical patent/IN2013MU02286A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN2286MU2013 2013-07-08 2013-07-08 IN2013MU02286A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2286MU2013 IN2013MU02286A (zh) 2013-07-08 2013-07-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2286MU2013 IN2013MU02286A (zh) 2013-07-08 2013-07-08

Publications (1)

Publication Number Publication Date
IN2013MU02286A true IN2013MU02286A (zh) 2015-06-19

Family

ID=54396531

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2286MU2013 IN2013MU02286A (zh) 2013-07-08 2013-07-08

Country Status (1)

Country Link
IN (1) IN2013MU02286A (zh)

Similar Documents

Publication Publication Date Title
MX2016010213A (es) Formulaciones farmaceuticas novedosas.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2021006969A (es) Ligante peptidico.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12015500823A1 (en) Modified release formulations for oprozomib
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
UA117154C2 (uk) Антагоністи s1p3
TN2015000386A1 (en) Formulations of organic compounds
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
GR1008228B (el) Φαρμακευτικο σκευασμα περιεχον ενα διπλο αναστολεα επαναπροσληψης και μεθοδος για την παρασκευη αυτου
MX2017013633A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde particulas.
SA516370446B1 (ar) تركيبة صيدلانية مستقرة مضادة للدرن في صورة قرص قابل للتشتت يحتوي على حبيبات إيزونيازيد وحبيبات ريفابنتين، وعملية لتحضيرها
EA201991286A1 (ru) Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
PH12020500120A1 (en) Pharmaceutical compositions
IN2013MU02286A (zh)
IN2013MU02366A (zh)
GR1008819B (el) Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου
MX2015011099A (es) Composiciones farmaceuticas de donepezilo que tienen un perfil de disolución in vitro o parámetros farmacocinéticos específicos.
IN2013MU02442A (zh)
EA201992754A1 (ru) Фармацевтические композиции
TH132242B (th) องค์ประกอบทางเภสัชกรรมที่ประกอบด้วยไฮโดรมอร์โฟนและนาล็อกโซน (Pharmaceutical compositions comprising hydromorphone and naloxone)